[go: up one dir, main page]

RU2012125938A - METHOD FOR TREATING EXUDATIVE FORM OF AGE-RELATED MACULAR DEGENERATION - Google Patents

METHOD FOR TREATING EXUDATIVE FORM OF AGE-RELATED MACULAR DEGENERATION Download PDF

Info

Publication number
RU2012125938A
RU2012125938A RU2012125938/14A RU2012125938A RU2012125938A RU 2012125938 A RU2012125938 A RU 2012125938A RU 2012125938/14 A RU2012125938/14 A RU 2012125938/14A RU 2012125938 A RU2012125938 A RU 2012125938A RU 2012125938 A RU2012125938 A RU 2012125938A
Authority
RU
Russia
Prior art keywords
macular degeneration
related macular
age
exudative form
treating exudative
Prior art date
Application number
RU2012125938/14A
Other languages
Russian (ru)
Inventor
Турсунгуль Кобжасаровна Ботабекова
Майра Беримжановна Имантаева
Зауреш Турсуновна Утельбаева
Нэйля Ахметовна Алдашева
Венера Равилевна Абдуллина
Original Assignee
АО "Казахский ордена "Знак Почета" научно-исследовательский институт глазных болезней" Министерства здравоохранения Республики Казахстан
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by АО "Казахский ордена "Знак Почета" научно-исследовательский институт глазных болезней" Министерства здравоохранения Республики Казахстан filed Critical АО "Казахский ордена "Знак Почета" научно-исследовательский институт глазных болезней" Министерства здравоохранения Республики Казахстан
Priority to RU2012125938/14A priority Critical patent/RU2012125938A/en
Publication of RU2012125938A publication Critical patent/RU2012125938A/en

Links

Landscapes

  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Способ лечения возрастной макулярной дегенерации, включающий реваскуляризацию хориоидеи путем выполнения разреза конъюнктивы и склеры и введения в супрахориоидальное пространство материального объекта, отличающийся тем, что в качестве материального объекта в супрахориоидальное пространство имплантируют хитозановую пленку.A method of treating age-related macular degeneration, including revascularization of the choroid by performing a conjunctiva and sclera incision and introducing a material object into the suprachoroid space, characterized in that a chitosan film is implanted into the suprachoroid space.

Claims (1)

Способ лечения возрастной макулярной дегенерации, включающий реваскуляризацию хориоидеи путем выполнения разреза конъюнктивы и склеры и введения в супрахориоидальное пространство материального объекта, отличающийся тем, что в качестве материального объекта в супрахориоидальное пространство имплантируют хитозановую пленку. A method of treating age-related macular degeneration, including revascularization of the choroid by performing a conjunctiva and sclera incision and introducing a material object into the suprachoroid space, characterized in that a chitosan film is implanted into the suprachoroid space.
RU2012125938/14A 2012-06-21 2012-06-21 METHOD FOR TREATING EXUDATIVE FORM OF AGE-RELATED MACULAR DEGENERATION RU2012125938A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2012125938/14A RU2012125938A (en) 2012-06-21 2012-06-21 METHOD FOR TREATING EXUDATIVE FORM OF AGE-RELATED MACULAR DEGENERATION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2012125938/14A RU2012125938A (en) 2012-06-21 2012-06-21 METHOD FOR TREATING EXUDATIVE FORM OF AGE-RELATED MACULAR DEGENERATION

Publications (1)

Publication Number Publication Date
RU2012125938A true RU2012125938A (en) 2013-12-27

Family

ID=49785940

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2012125938/14A RU2012125938A (en) 2012-06-21 2012-06-21 METHOD FOR TREATING EXUDATIVE FORM OF AGE-RELATED MACULAR DEGENERATION

Country Status (1)

Country Link
RU (1) RU2012125938A (en)

Similar Documents

Publication Publication Date Title
MX2020001340A (en) Cellular models of and therapies for ocular diseases.
HK1258588A1 (en) Compounds and formulations for treating ophthalmic diseases
CA2900779C (en) Compositions and methods for treating neurodegenerative diseases and cardiomyopathy
MX2016009331A (en) Compositions and methods for treating ocular diseases.
WO2015148863A3 (en) Crispr/cas-related methods and compositions for treating sickle cell disease
MX2021008663A (en) ENHANCED ANTIBODIES AGAINST IL-6.
MX2017002374A (en) Compositions and methods to treat vision disorders.
MX392383B (en) METHODS FOR TREATING EYE CONDITIONS.
EP4420726A3 (en) Fixed dose combination of bromonidine and timolol
GB2541840A (en) Ophthalmic composition for the treatment of ocular infection
CL2015002689A1 (en) Methods to inhibit cataracts and presbyopia.
MX2016006334A (en) METHODS OF TREATMENT OF EYE DISEASES WITH AN IMPLANT FOR THE SUSTAINED ADMINISTRATION OF PHARMACOS.
EP3691654A4 (en) Ophthalmic pharmaceutical compositions and methods for treating ocular surface disease
MX383754B (en) COMPOSITIONS FOR USE IN THE TREATMENT OF GLUTEN INTOLERANCE AND RELATED CONDITIONS.
MX2020012011A (en) Prostaglandin conjugates and derivatives for treating glaucoma and ocular hypertension.
EP3634438A4 (en) Compositions for treating retinal diseases and methods for making and using them
EP3859715A4 (en) Simulated sclera and simulated eyeball
EP3658217A4 (en) TREATMENT OF EYE DISEASES
MX2016009600A (en) Agents for use in the treatment of retinal inflammation.
RU2014140798A (en) A method for the correction of fibro-altered filtration pads arising in the postoperative period during glaucoma surgery
SI3720428T1 (en) Ophthalmic topical composition comprisng dobesilic acid for treating diseases of the posterior segment of the eye
RU2012125938A (en) METHOD FOR TREATING EXUDATIVE FORM OF AGE-RELATED MACULAR DEGENERATION
MX2018003799A (en) Novel ophthalmic composition comprising rebamipide and method for preparing the same.
EA201992515A1 (en) COMPOSITIONS AND METHODS FOR TREATING RETINOPATHY
TR201902864T4 (en) Reduced central corneal thickening by the use of hydrophilic ester prodrugs of beta-chlorocyclopentanes.

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20140304